Ampio pharmaceuticals to participate at the 34th annual roth conference

Englewood, colo., march 9, 2022 /prnewswire/ -- ampio pharmaceuticals, inc. (nyse american: ampe), a biopharmaceutical company focused on the advancement of immunomodulatory therapies for the treatment of pain resulting from osteoarthritis, will attend the 34th annual roth conference, which is being held in laguna niguel, california from march 13-15, 2022.
AMPE Ratings Summary
AMPE Quant Ranking